OSCR

Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion.

Overview

Authors: Lily Keane1,2,3, Martin Škandík1,4, Mercedes Posada-Pérez1,5, Raj Bose5,6, John Desito7, Esmee van der Linde5,6, Pinelopi Engskog-Vlachos1,5, Sandra Ceccatelli5,6, Adam L Green7, Bertrand Joseph1,5
  1. Institute of Environmental Medicine, Toxicology unit, Karolinska Institutet, Stockholm, Sweden
  2. Present Address: APC Microbiome Ireland, University College Cork, Cork, Ireland
  3. Present Address: Department of Anatomy & Neuroscience, University College Cork, Cork, Ireland
  4. Present Address: Ribocure Pharmaceuticals AB, Gothenburg, Sweden
  5. Center for Neuromusculoskeletal Restorative Medicine, Hong Kong Science Park, Shatin, Hong Kong, China
  6. Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
  7. Morgan Adams Foundation Pediatric Brain Tumor Research Foundation, Department of Pediatrics, University of Colorado Anschutz Medical Campus Aurora, Aurora, CO USA
Journal: Cell death & disease, volume 17, issue 1, article 517
Dates: received 11 November 2025; accepted 14 May 2026; published online 30 May 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1038/s41419-026-08891-y · PMID 42218137 · PMCID PMC13222350 · OpenAlex W7162851512
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), other condition (population), cellular / molecular (subfield)
Methods: fMRI & imaging, Statistics
Keywords: CNS cancer, Microglial cells
MeSH: Brain Neoplasms*, Extracellular Matrix*, Glioma*, Microglia*, Animals, Cell Line, Tumor, Fibronectins, Gene Expression Regulation, Neoplastic, Humans, Neoplasm Invasiveness (* major topic)
Topic: Glioma Diagnosis and Treatment (Oncology, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 69 references in the paper
Research resources: BV-2 microglia RRID:CVCL_0182, primary patient-derived SF188 pHGG cells RRID:CVCL_6948, SU-DIPG-XVII RRID:CVCL_C1MW, primary-patient derived SU-DIPG-XIII RRID:CVCL_IT41, RRID:CVCL_IT46

Abstract

Diffuse midline glioma, H3K27-altered (DMG), is an aggressive and uniformly fatal paediatric brain tumour arising in midline structures and characterised by substantial microglial infiltration. We investigated whether microglia adopt a reactive state in response to DMG cells that functionally contributes to tumour progression. Transcriptomic profiling of microglia exposed to DMG, H3K27M cells, together with analysis of tumour associated myeloid cells isolated from DMG patient biopsies, revealed a pronounced upregulation of extracellular matrix (ECM) components, including fibronectin. Single cell transcriptomic analysis further identified microglia as the primary fibronectin expressing cell population within human DMG, H3K27M tumours. Functional invasion assays using a panel of patient-derived DMG, H3K27M cells, revealed that microglia-derived fibronectin significantly enhances tumour cell invasiveness, while its chemical inhibition with RGDS peptide or Avapritinib or its genetic silencing using small-interfering RNAs effectively suppresses invasion. Across independent patient cohorts (Kids First, PNOC, and CBTTC), and in archival tissues, DMG tumours were found to exhibit elevated expression of ECM components, and high fibronectin expression that correlated with poor prognosis. These findings suggest that microglia actively contribute to DMG invasiveness through ECM component production, identifying fibronectin as a potential therapeutic target in this lethal paediatric cancer.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

The transcriptome dataset comparing BV-2 microglia exposed to SF8628 DMG cells or SF188 pHGG cells is available at the Gene Expression Omnibus with accession number: GSE309866. The bulk RNA-seq and scRNA-seq from human DMG biopsies are already published [24, 41]. All other data are available from the corresponding author upon reasonable request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Funding: added Vetenskapsrådet

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 2 keywords, 10 MeSH terms, 69 references, 5 RRIDs.

Cite

This paper

Keane, L., Škandík, M., Posada-Pérez, M., Bose, R., Desito, J., van der Linde, E., Engskog-Vlachos, P., Ceccatelli, S., Green, A. L., & Joseph, B. (2026). Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion. Cell death & disease, 17(1), 517. https://doi.org/10.1038/s41419-026-08891-y

BibTeX

@article{keane2026microglia,
author = {Keane, Lily and Škandík, Martin and Posada-Pérez, Mercedes and Bose, Raj and Desito, John and van der Linde, Esmee and Engskog-Vlachos, Pinelopi and Ceccatelli, Sandra and Green, Adam L and Joseph, Bertrand},
title = {{Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion}},
journal = {Cell death \& disease},
year = {2026},
month = may,
volume = {17},
number = {1},
pages = {517},
publisher = {Nature Publishing Group},
issn = {2041-4889},
doi = {10.1038/s41419-026-08891-y},
url = {https://doi.org/10.1038/s41419-026-08891-y},
pmid = {42218137},
pmcid = {PMC13222350}
}

RIS

TY - JOUR
AU - Keane, Lily
AU - Škandík, Martin
AU - Posada-Pérez, Mercedes
AU - Bose, Raj
AU - Desito, John
AU - van der Linde, Esmee
AU - Engskog-Vlachos, Pinelopi
AU - Ceccatelli, Sandra
AU - Green, Adam L
AU - Joseph, Bertrand
TI - Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion
T2 - Cell death & disease
J2 - Cell Death Dis
PY - 2026
DA - 2026/05/30
VL - 17
IS - 1
SP - 517
SN - 2041-4889
PB - Nature Publishing Group
DO - 10.1038/s41419-026-08891-y
UR - https://doi.org/10.1038/s41419-026-08891-y
LA - en
ER -

CSL-JSON

{
"id": "10.1038/s41419-026-08891-y",
"type": "article-journal",
"title": "Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion",
"container-title": "Cell death & disease",
"author": [
{
"family": "Keane",
"given": "Lily"
},
{
"family": "Škandík",
"given": "Martin"
},
{
"family": "Posada-Pérez",
"given": "Mercedes"
},
{
"family": "Bose",
"given": "Raj"
},
{
"family": "Desito",
"given": "John"
},
{
"family": "van der Linde",
"given": "Esmee"
},
{
"family": "Engskog-Vlachos",
"given": "Pinelopi"
},
{
"family": "Ceccatelli",
"given": "Sandra"
},
{
"family": "Green",
"given": "Adam L"
},
{
"family": "Joseph",
"given": "Bertrand"
}
],
"container-title-short": "Cell Death Dis",
"volume": "17",
"issue": "1",
"page": "517",
"DOI": "10.1038/s41419-026-08891-y",
"PMID": "42218137",
"PMCID": "PMC13222350",
"ISSN": "2041-4889",
"publisher": "Nature Publishing Group",
"URL": "https://doi.org/10.1038/s41419-026-08891-y",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
30
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41420-025-02295-1
Age-associated microglial transcriptome leads to diminished immunogenicity and dysregulation of MCT4 and P2RY12/P2RY13 related functions.
Journal: Cell death discovery
In common: cellular / molecular, 3 references, 4 authors
[2] doi:10.1038/s41593-023-01326-3
ARG1-expressing microglia show a distinct molecular signature and modulate postnatal development and function of the mouse brain.
Journal: Nature neuroscience
In common: 3 references, 3 authors
[3] doi:10.1038/s41419-024-06903-3
ID2-ETS2 axis regulates the transcriptional acquisition of pro-tumoral microglia phenotype in glioma.
Journal: Cell death & disease
In common: other condition, cellular / molecular, 5 references, 2 authors
[4] doi:10.1073/pnas.2416614121
An E2 ubiquitin-conjugating enzyme links diubiquitinated H2B to H3K27M oncohistone function.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: other condition, cellular / molecular, 9 references
[5] doi:10.1002/glia.24189
A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M.
Journal: Glia
In common: other condition, cellular / molecular, 9 references
[6] doi:10.1016/j.ccell.2025.12.020
IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline glioma.
Journal: Cancer cell
In common: other condition, cellular / molecular, 9 references
[7] doi:10.1038/s41467-025-66521-1 [code]
Human oligodendrocyte progenitor cells mediate synapse elimination through TAM receptor activation.
Journal: Nature communications
In common: cellular / molecular, 1 reference, 2 authors
[8] doi:10.1186/s40478-025-01952-x
Spatial analysis of a complete DIPG-infiltrated brainstem reveals novel ligand-receptor mediators of tumour-to-TME crosstalk.
Journal: Acta neuropathologica communications
In common: other condition, cellular / molecular, 8 references
[9] doi:10.1172/jci170329
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.
Journal: The Journal of clinical investigation
In common: other condition, 7 references
[10] doi:10.1038/s41586-024-08579-3
GABAergic neuron-to-glioma synapses in diffuse midline gliomas.
Journal: Nature
In common: other condition, cellular / molecular, 7 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.